Current state of diagnosis and endovascular treatment of renal artery stenosis

Vasa - Journal of Vascular Diseases

Volumn 35, Issue 3, 2006, Pages 147-155

  Zeller, Thomas ^a  

^a UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

Author keywords

Angioplasty; Hypertension; Left ventricular hypertrophy; Renal artery stenosis; Renal function

Indexed keywords

ANTIHYPERTENSIVE AGENT; CONTRAST MEDIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; RAPAMYCIN;

ANGIOPLASTY; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; CLINICAL FEATURE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CREATININE BLOOD LEVEL; DOPPLER ECHOGRAPHY; DRUG ELUTING STENT; ENDOVASCULAR SURGERY; FIBROMUSCULAR DYSPLASIA; HEART LEFT VENTRICLE HYPERTROPHY; HEMODIALYSIS; HEMODYNAMICS; HUMAN; HYPERTENSION; KIDNEY ARTERY STENOSIS; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY ISCHEMIA; MAGNETIC RESONANCE ANGIOGRAPHY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RESTENOSIS; REVASCULARIZATION; REVIEW; STENT; SURVIVAL;

ANGIOGRAPHY; ANGIOPLASTY, BALLOON; ATHEROSCLEROSIS; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPERTENSION, RENAL; HYPERTROPHY, LEFT VENTRICULAR; RENAL ARTERY OBSTRUCTION; STENTS; TREATMENT OUTCOME;

EID: 33748526860     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526.35.3.147     Document Type: Review

References (104)

1. Aspelin P, Aubry P, Fransson SG et al. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003; 348: 491-9.
2. Baert AL, Wilms G, Amery A et al. Percutaneous transluminal renal angioplasty: Initial results and long-term follow-up in 202 patients. Cardiovasc Intervent Radiology 1990; 13: 22-8.
3. Baumgartner I, Behrendt P, Rohner P et al. A validation study on the intraobserver and interobserver reproducibility of renal artery duplex ultrasound. Ultrasound Med Biol 1999; 25(2): 225-31.
4. Beutler JJ, van Ampting JM, van de Ven PJ et al. Long-term effects of renal artery stenting on kidney function for patients with ostial atherosclerotic renal artery stenosis and renal insufficiency. J Am Soc Nephrol 2001; 1475-81.
5. Blum U, Krumme B, Flügel P et al. Treatment of ostial renal-artery stenoses with vascular endoprotheses after unsuccessful balloon angioplasty. N Engl J Med 1997; 336: 459-65.
6. Boisclair C, Therasse E, Oliva VL et al. Treatment of renal angioplasty failure by percutaneous renal artery stenting with Palmaz Stents. Midterm technical and clinical results. AJR 1997; 168: 245-51.
7. Bonelli FS, McKusick A, Textor SC et al. Renal artery angioplasty: Technical results and clinical outcome in 320 patients. Mayo Clin Proc 1995; 70: 1041-52.
8. Border WA, Noble NA. Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis. Hypertension 1998; 31: 161-88.
9. Canzanello VJ, Millan VG, Spiegel JE et al. Percutaneous renal angioplasty in management of atherosclerotic renovascular hypertension: results in 100 patients. Hypertension 1989; 163-72.
10. Caps MT, Zierler RE, Polissar NL et al. Risk of atrophy in kidneys with atherosclerotic renal artery stenosis. Kidney Int 1998; 53: 735-42.
11. Casale PN, Devereux RB, Milner M et al. Value of echocardiographic left ventricular mass in predicting cardiovascular morbide vents in hypertensive men. Ann Intern Med 1986; 105: 173-8.
12. Cluzel P, Raynaud A, Beyssen B et al. Stenoses of renal branch arteries in fibromuscular dysplasia: Results of percutaneous transluminal angioplasty. Radiology 1994; 193: 227-32.
13. Dean RH, Tribble RW, Hansen KJ et al. Evolution of renal insufficiency in ischemic nephropathy. Ann Surg 1991; 213: 446-55.
14. Dinkel HP, Hoppe H, Baumgartner I et al. Einsatz von niederosmolarem Gadolinium zur angiographisehen Darstellung und bei interventionell- radiologischen Eingriffen bei niereninsuffizienten Patienten. Fortschr Röntgenstr 2002; 174: 56-61.
15. Dorros G, Prince C, Mathiak L. Stenting of renal artery stenosis achieves better relief of the obstructive lesion than balloon angioplasty. Cath Cardiovasc Diagn 1993; 29: 191-98.
16. Dorros G, Jaff M, Mathiak L et al. 4-year follow-up of Palmaz-Schatz stent revascularisation as treatment for atherosclerotic renal artery stenosis. Circulation 1998; 98: 642-47.
17. Dorros G, Jaff M, Mathiak L et al. Multicenter Palmaz stent renal artery stenosis revascularization registry report: Four-year follow-up of 1058 successful patients. Cathet Cardiovasc Intervent 2002; 55: 182-88.
18. Erdoes L, Berman SS, Hunter GC et al. Comparative analysis of percutaneous transluminal angioplasty and operation for renal revascularization. Am J Kidney Dis 1996; 27: 496-503.
19. Goncharenko V, Gerlock AJ, Shaff MI et al. Progression of renal artery fibromuscular dysplasia in 42 patients as seen in angiography. Radiology 1981; 139: 145-51.
20. Greco BA, Breyer JA. The natural history of renal artery stenosis: who should be evaluated for ischemic nephropathy. Semin Nephrol 1996; 16: 2-11.
21. Grist TM. Magnetic resonance angiography of renal arterial stenosis. Coron Artery Dis 1999; 10: 151-156.
22. Gross CM, Krämer J, Waigand J et al. Ostial renal artery stent placement for atherosclerotic renal artery stenosis in patients with coronary artery disease. Cath Cardiovasc Diagn 1998; 45: 1-8.
23. Guo Z, Fenster A. Three-dimensional power Doppler imaging: A phantom study to quantify vessel stenosis. Ultrasound Med Biol 1996; 22: 1059-69.
24. Halpern EJ, Nazarian LN, Wechsler RJ et al. US, CT, and MR evaluation of accessory renal arteries and proximal renal arterial branches. Acad-Radiol. 1999; 6(5): 299-304.
25. Hansen KJ, Lundberg AH, Benjamin ME et al. Is renal revascularization in diabetic patients worthwile. J Vasc Surg 1996; 24: 383-93.
26. Harden PN, Sheppard D, Rodger RSC et al. Percutaneous transluminal renal angioplasty (PTRA) in the treatment of chronic renal failure due to renovascular disease. J Nephrol 1994; 7: 186-88.
27. Harden PN, MacLeod MJ, Rodger RSC et al. Effect of renal-artery stenting on progression of renovascular renal failure. Lancet 1997; 349: 1133-6.
28. Harding MB, Smith LR, Himmelstein SI et al. Prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol 1992; 2: 1608.
29. Henry M, Amor M, Henry I et al. Stent placement in the renal artery: Three-year experience with the Palmaz stent. J Vasc Interven Radiol 1996; 7: 343-50.
30. Henry M, Klonaris C, Henry I et al. Protected renal stenting with the PercuSurge GuardWire device: a pilot study. J Endovasc Ther 2001; 8: 227-37.
31. Hollenberg NK. Medical therapy of renovascular hypertension: efficacy and safety of Captopril in 269 patients. Cardiovasc Rev Rep 1983; 4: 852-76.
32. Hortling N, Strunk H, Wilhelm K et al. Die Darstellbarkeit der Nierenarterien und Wertigkeit der farbkodierten Duplexsonographie der Nierenarterienstenosen unter Verwendung eines Ultraschall- Signalverstärkers. Röfo Fortschr Röntgenstr Neue Bildgeb Verfahr 1998; 169(4): 397-401.
33. Hricik DE, Browning PJ, Kopelman R et al. Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or stenosis in a solitary kidney. N Engl J Med 1983; 308: 373-76.
34. Ianonne LA, Underwood PL, Nath A et al. Effect of primary balloon expandable renal artery stents on long-term patency, renal function, and blood pressure in hypertensive and renal insufficient patients with renal artery stenosis. Cath Cardiovasc Diagn 1996; 37: 243-50.
35. Jean WJ, al-Bitar I, Zwicke DL et al. High incidence of renal artery stenosis in patients with coronary artery disease. Cath Cardiovasc Diagn 1994; 32: 8-10.
36. Jensen G, Zachrisson BF, Delin K et al. Treatment of renovascular hypertension: One year results of renal angioplasty. Kidney Int 1995; 48: 1936-45.
37. Klinge J, Mali WPTM, Puijlaert CABJ et al. Percutaneous transluminal renal angioplasty: Initial and long-term results. Radiology 1989; 171: 501-6.
38. Karasch T, Rubin J. Diagnosis of renal artery stenosis and renovascular hypertension. Eur J Ultrasound 1998; 7Suppl.: 27-39.
39. Korsakas S, Mohaupt MG, Dinkel HP, Mahler F, Do DD, Voegele J, Baumgartner I. Delay of dialaysis in end-stage renal failure: Prospective study on percutaneous renal artery interventions. Kidney International 2004; 65: 251-8.
40. Krumme B, Blum U, Schwertfeger E et al. Diagnosis of renovascular disease by intrarenal and extrarenal Doppler scanning. Kidney Int 1996; 50: 1288-92.
41. La Batide-Alanore A, Azizi M, Froissart M et al. Split renal function outcome after renal angioplasty in patients with unilateral renal artery stenosis. J Am Soc Nephrol 2001; 12: 1235-41.
42. Lederman RJ, Mendelsohn FO, Santos R et al. Primary renal artery stenting: characteristics and outcomes after 363 procedures. Am Heart J 2001; 142: 314-23.
43. Levy D, Garrison RJ, Savage D et al. Left ventricular mass and incidence of coronary heart disease in an elderly cohort: the Framingham Heart Study. Ann Intern Med 1989; 110: 101-7.
44. Levy D, Garrison RJ, Savage D et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561-6.
45. Levy D, Larson MG, Vasan RS et al. The progression from hypertension to congestive heart failure. JAMA 1996; 275: 1557-62.
46. Mailloux LU, Napolitano B, Bellucci AG et al. Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: A 20-year clinical experience. Am J Kidney Diseases 1994; 4: 622-29.
47. Martin LG, Cork RD, Kaufman SL. Long-term results of angioplasty in 110 patients with renal artery stenosis. J Vasc Interven Radiol 1992; 3: 619-26.
48. Mikkonen RH, Kreula JM, Virkkunen PJ. Reliability of Doppler ultrasound in follow-up studies. Acta-Radiol 1998; 39(2): 193-9.
49. Missouris CG, Buckenham T, Cappuccio FP et al. Renal artery stenosis: A common and important problem in patients with peripheral vascular disease. Am J Med 1994; 96: 10-4.
50. Mueller C, Buerkle G, Buettner HJ et al. Prevention of Contrast Media-Associated Nephropathy: Randomized Comparison of two Hydration Regimens in 1620 Patients undergoing Coronary Angioplasty. Archives of Internal Medicine 2002, 162: 329-36.
51. Mustert BR, Williams DM, Prince MR. In vitro model of arterial stenosis: correlation of MR signal dephasing and trans-stenotic pressure gradients. Magn Reson Imaging 1998; 16: 301-10.
52. Olin JW, Piedmonte MR, Young JR et al. The utility of Duplex ultrasound scanning of the renal arteries for diagnosing significant renal artery stenosis. Ann Intern Med 1995; 122: 833-8.
53. Pattynama P, Becker GJ, Brown J et al. Percutaneous Angioplasty for Atherosclerotic Renal Artery Disease: Effect on Renal Function in Azotemic Patients. Cardiovasc Intervent Radiol 1994; 17: 143-6.
54. Plouin PF, Chatellier G, Darne B et al. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: Arandomized trail. The EMMA-study group. Hypertension 1998; 31: 823-9.
55. Radermacher J, Chavan A, Bleck J et al. Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med 2001; 334: 410-7.
56. Ramsey LE, Waller PC. Blood pressure response to percutaneous transluminal angioplasty for renovascular hypertension: an overview of published series. Br Med J 1990: 569-72.
57. Rimmer JM, Gennari FJ. Atherosclerotic renovascular disease and progressive renal failure. Ann Intern Med 1993; 118: 712-9.
58. Rocha-Singh KJ, Ahuja RK, Sung CH et al: Long-term renal function preservation after renal artery stenting in patients with progressive ischemic nephropathy. Catheter Cardiovasc Interv 2002; 57: 135-41.
59. Rundback JH, Sacks D, Kent KC et al. Guidelines for the reporting of renal artery revascularization in clinical trials. Circulation 2002; 106: 1572-85.
60. Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med 2001; 344: 431-42.
61. Sang CN, Whelton PK, Hamper U et al. Etiologic factors of renovascular fibromuscular dysplasia: a case-controlled study. Hypertension 1989; 14: 472-9.
62. Sapoval M, Zähringer M, Pattynama P, Rabbia C, Vignali C et al. Low-profile stent system for treatment of atherosclerotic renal artery stenosis: The GREAT Trial. J Vasc Interv Radiol 2005; 16: 1195-202.
63. Schreiber MJ, Pohl MA, Novick AC. The natural history of atherosclerotic and fibrous renal artery disease. Urol Clin North Am 1984; 11: 383-92.
64. Schreier DZ, Weaver FA, Frankhouse J et al. A prospective study of carbon dioxide digital substraction vs standard arteriography in the evaluation of renal arteries. Arch Surg 1996; 131: 503-7.
65. Schwerk WB, Restrepro-Specht I, Stellwaag M. Nierenarterienstenose: Diagnose durch Messung intrarenaler arterieller Widerstandsindices. Ultraschall Klin Prax 1992; 7: 238.
66. Schwerk WB, Restropro I, Stellwaag M et al. Renal artery stenoses: non invasive diagnosis and grading with image directed Doppler US evaluation of the renal resistive index. Radiology 1994; 190: 785-90.
67. Shanly PF. The pathology of chronic renal ischemia. Semin Nephrol 1996; 16: 21-32.
68. Shannon HM, Gillespie IN, Moss JG. Salvage of the solitary kidney by insertion of a renal artery stent. Am J Roentgenol 1998; 171: 217-22.
69. Sigmon DH, Beierwaltes WH. Renal nitric oxide and angiotensin II interaction in renovascular hypertension. Hypertension 1993; 22: 237-42.
70. Sos TA, Pickering TG, Sniderman K et al. Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia. N Engl J Med 1983; 309: 274-9.
71. Strunk H, Schild H, Mortasawi MA. Arterial interventional measures using carbon dioxide (CO2) as a contrast medium. Rofo Fortschr Geb Rontgenstr Neue Bildgeb Verfahr 1992; 157: 599-600.
72. Symonides B, Chodakowska J, Januszewicz A et al. Effects of the correction of renal artery stenosis on blood pressure, renal function and left ventricular morphology. Blood Pressure 1999; 8: 141-50.
73. Taylor A, Sheppard D, MacLeod MJ et al. Renal artery stent placement in renal artery stenosis: Technical and early clinical results. Clin Radiology 1997; 52: 451-57.
74. Tepel M, Van der Giet M, Schwarzfeld C et al. Prevention of radiographic-contrast agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000; 343: 180-4.
75. Textor SC. Pathophysiology of renal failure in renovascular disease. Am J Kidney Dis 1994; 24: 642-51.
76. Tollefson DFJ, Ernst CB. Natural history of atherosclerotic renal artery stenosis associated with aortic disease. J Vasc Surg 1991; 14: 327-31.
77. Toto RD, Mitchell HC, Lee HC et al. Reversible renal insufficiency due to angiotensin converting enzyme inhibitors in hypertensive nephrosclerosis. Ann Intern Med 1991; 115: 513-9.
78. Van Bockel JH, Weibull H. Fibrodysplastic disease of renal arteries. Eur J Vasc Surg 1994; 8: 655-7.
79. Van de Ven PJG, Beutler JJ, Kaatee R et al. Transluminal vascular stent for ostial atherosclerotic renal artery stenosis. Lancet 1995; 346: 672-4.
80. Van de Ven PJG, Kaatee R, Beutler JJ et al. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trail. Lancet 1999; 353: 282-6.
81. Van Jaarsveld BC, Krijnen P, Pieterman H et al for the Dutch Renal Artery Stenosis Intervention Cooperative Study Group. The Effect of Balloon Angioplasty on Hypertension in Atherosclerotic Renal-Artery Stenosis. N Engl J Med 2000; 342: 1007-14.
82. Vasan RS, Levy D. The role of hypertension in the pathogenesis of heart failure: a clinical mechanistic overview. Arch Intern Med 1996; 156: 1789-96.
83. Vasan RS, Evans JC, Larson MG et al. Serum aldosterone and the incidence of hypertension in nonhypertensive persons. N Engl J Med 2004; 351: 8-10.
84. Vasan RS, Evans JC, Benjamin EJ et al. Relations of serum aldosterone to cardiac structure: gender-related differences in the Framingham Heart Study. Hypertension 2004; 43: 957-62.
85. Vensel LA, Devereux RB, Pickering TG et al. Cardiac structure and function in renovascular hypertension produced by unilateral and bilateral renal artery stenosis. Am J Cardiol 1986; 57: 1388-93.
86. Vetrovec GW, Landwehr DM, Edwards VL. Incidence of renal artery stenosis in hypertensive patients undergoing coronary angiography. J Intervent Cardiol 1989; 2: 69.
87. von Knorring J, Edgren J, Lepäntalo M. Long-term results of percutaneous transluminal angioplasty in renovascular hypertension. Acta Radiologica 1996; 37: 36-40.
88. Watson PS, Hadjipetrou P, Cox SV et al. Effect of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease. Circulation 2000; 102: 1671-7.
89. Webster J, Marshall F, Abdalla M et al. Randomized comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. J Hum Hypertens 1998; 12: 329-35.
90. White CJ, Ramee SR, Collins TJ et al. Renal artery stent placement: Utility in lesions difficult to treat with balloon angioplasty. J Am Coll Cardiol 1999; 30: 1445-50.
91. Yoshitomi Y, Nishikimi T, Abe H et al. Comparison of changes in cardiac structure after treatment in secondary hypertension. Hypertension 1996; 27: 319-23.
92. Zeller T, Frank U, Späth M. Detection of Renal Arteries and Classification of Hemodynamically Relevant Renal Artery Stenoses by Colour Coded Doppler Ultrasound. Zeitschr Ultraschall Med 2001; 22: 116-21.
93. Zeller T, Frank U, Müller C, Bürgelin K, Schwarzwälder U, Horn B, Neumannn FJ. Farbduplexsonographie zur Verlaufskontrolle nach Stent-PTRA ostialer Nierenarterienstenose. Z Ultraschall Med 2002; 23: 315-9.
94. Zeller T, Müller C, Frank U et al. Gold coating and restenosis after primary stenting of ostial renal artery stenosis. Cath Cardiovasc Intervent 2003; 60: 1-6.
95. Zeller T, Frank U, Müller C et al. Technological advances in the design of catheters and devices used in renal artery interventions: impact on complications. J Endovasc Ther 2003; 10: 1006-14.
96. Zeller T, Müller C, Frank U et al. Stent-angioplasty of severe atherosclerotic ostial renal artery stenosis in patients with diabetes mellitus and nephrosclerosis. Cath Cardiovasc Interven 2003; 58: 510-5.
97. Zeller T, Frank U, Müller C et al. Predictors of improved renal function after primary stenting of severe atherosclerotic ostial renal artery stenosis. Circulation 2003; 108: 2244-9.
98. Zeller T, Frank U, Müller C et al. Stent-supported angioplasty of severe atherosclerotic renal artery stenosis preserves renal function and improves blood pressure control: Long-term results of a prospective registry with 456 lesions. J Endovasc 2004; 11: 95-106.
99. Zeller T, Müller C, Frank U et al. Percutaneous transluminal angioplasty using gadoaiamide as an alternative contrast agent in patients with contraindications to iodine-containing contrast agents. J Endovasc Ther 2002; 9: 625-32.
100. Zeller T, Müller C, Frank U et al. Survival after stent-angioplasty of severe atherosclerotic ostial renal artery stenoses. J Endovasc Ther 2003; 10: 539-45.
101. Zeller T. Renal artery stenosis: Epidemiology, clinical manifestation and percutaneous endovascular therapy. J Intervent Cardiol 2005; 18: 497-506.
102. Zeller T, Rastan A, Kliem M, Schwarzwälder U, Frank U, Bürgelin K, Schwarz T, Amantea P, Müller C, Neumann FJ. Impact of Carbon Coating on Restenosis Rate After Stenting of Atherosclerotic Renal Artery Stenosis. J Endovasc Ther 2005; 12: 605-11.
103. Zierler RE, Bergelin RO, Davidson CD et al. A prospective study of disease progression in patients with atherosclerotic renal artery stenosis. AJH 1996; 9: 1055-61.
104. Zierler RE, Bergelin RO, Isaacson JA et al. Natural history of atherosclerotic renal artery stenosis: A prospective study with duplex ultrasonography. J Vasc Surg 1994; 19: 250-8.